Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy
- PMID: 18063419
- PMCID: PMC3712273
- DOI: 10.1016/j.cgh.2007.10.006
Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy
Abstract
Background & aims: The incidence of esophageal adenocarcinoma (EAC) in blacks and Hispanics is well-described, but racial differences in the risk of Barrett's esophagus (BE) have not been directly studied. It is important to determine whether race and ethnicity can be identified as risk factors for the development of metaplasia, neoplastic progression, or both.
Methods: We performed a single center retrospective cross-sectional analysis of all patients who underwent upper endoscopy during a 1-year period. Patients with a prior endoscopy within 5 years or known BE or EAC were excluded. Suspected cases of BE were confirmed by pathology report.
Results: A total of 2100 patients met inclusion criteria. Whites (37.7%), blacks (11.8%), and Hispanics (22.2%) comprised the majority. Whites had a significantly higher prevalence of BE than Hispanics (6.1% vs 1.7%, P = .0002) and blacks (6.1% vs 1.6%, P = .004). In multivariable analysis, factors associated with decreased risk of BE were black race (odds ratio [OR], 0.34; 95% confidence interval [CI], 0.12-0.97) and Hispanic ethnicity (OR, 0.38; 95% CI, 0.18-0.84). Male sex (OR, 1.86; 95% CI, 1.20-2.87), reflux symptoms (OR, 2.87; 95% CI, 1.84-4.45), hiatal hernia (OR, 3.53; 95% CI, 2.17-5.72), and older age were associated with increased risk of BE.
Conclusions: Among patients who undergo upper endoscopy, blacks and Hispanics have a significantly lower prevalence of BE compared with whites. These differences in prevalence are comparable to the relative incidence rates observed with EAC, implying that progression from BE to adenocarcinoma does not vary by race/ethnicity. Reasons for lower rates of BE in Hispanics and blacks need further investigation.
Similar articles
-
Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.Am J Gastroenterol. 2012 Nov;107(11):1655-61. doi: 10.1038/ajg.2012.299. Epub 2012 Oct 2. Am J Gastroenterol. 2012. PMID: 23032983
-
Barrett's esophagus: prevalence and size of hiatal hernia.Am J Gastroenterol. 1999 Aug;94(8):2054-9. doi: 10.1111/j.1572-0241.1999.01277.x. Am J Gastroenterol. 1999. PMID: 10445527
-
Risk factors in the development of esophageal adenocarcinoma.Am J Gastroenterol. 2013 Feb;108(2):200-7. doi: 10.1038/ajg.2012.387. Epub 2012 Dec 18. Am J Gastroenterol. 2013. PMID: 23247577
-
Gastroesophageal reflux and cancer.Thorac Surg Clin. 2005 Aug;15(3):341-52. doi: 10.1016/j.thorsurg.2005.03.003. Thorac Surg Clin. 2005. PMID: 16104125 Review.
-
[Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].Minerva Chir. 2002 Dec;57(6):819-36. Minerva Chir. 2002. PMID: 12592224 Review. Italian.
Cited by
-
Lifestyle Risk Factors, Quality of Life, and Intervention Preferences of Barrett's Esophagus Patients: A Prospective Cohort Study.Glob Adv Health Med. 2021 Mar 8;10:21649561211001346. doi: 10.1177/21649561211001346. eCollection 2021. Glob Adv Health Med. 2021. PMID: 33767920 Free PMC article.
-
Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else?Curr Gastroenterol Rep. 2007 Dec;9(6):468-74. doi: 10.1007/s11894-007-0061-9. Curr Gastroenterol Rep. 2007. PMID: 18377797 Review.
-
The causal associations of circulating lipids with Barrett's Esophagus and Esophageal Cancer: a bi-directional, two sample mendelian randomization analysis.Hum Genomics. 2024 Apr 16;18(1):37. doi: 10.1186/s40246-024-00608-6. Hum Genomics. 2024. PMID: 38627859 Free PMC article.
-
Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.Gastrointest Endosc Clin N Am. 2021 Jan;31(1):27-41. doi: 10.1016/j.giec.2020.08.002. Epub 2020 Oct 21. Gastrointest Endosc Clin N Am. 2021. PMID: 33213798 Free PMC article. Review.
-
Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS3D) Is Cost-Effective in Barrett's Esophagus Screening.Dig Dis Sci. 2021 May;66(5):1572-1579. doi: 10.1007/s10620-020-06412-1. Epub 2020 Jun 23. Dig Dis Sci. 2021. PMID: 32578042 Free PMC article.
References
-
- Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004;99:582–588. - PubMed
-
- Cook MB, Wild CP, Forman D. A systematic review and metaanalysis of the sex ratio for Barrett’s esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005;162:1050–1061. - PubMed
-
- Shaheen NJ. Advances in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2005;128:1554–1566. - PubMed
-
- Conio M, Blanchi S, Lapertosa G, et al. Long-term endoscopic surveillance of patients with Barrett’s esophagus: incidence of dysplasia and adenocarcinoma—a prospective study. Am J Gastroenterol. 2003;98:1931–1939. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous